Composition
- Active ingredients
- AFLIBERCEPT-JBVF 2MG(0.05ML,40MG/ML)
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761274.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Yesafili
- Active substance
- aflibercept-jbvf
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Biocon Biologics Inc
- Status
- Prescription
- FDA approval
- 20 May 2024
- Application
- BLA761274-001